Your browser doesn't support javascript.
loading
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
Ozsvári, Béla; Lamb, Rebecca; Lisanti, Michael P.
Affiliation
  • Ozsvári B; The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
  • Lamb R; The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
  • Lisanti MP; The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
Aging (Albany NY) ; 8(4): 567-8, 2016 04.
Article in En | MEDLINE | ID: mdl-27038638
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Repositioning / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2016 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Repositioning / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2016 Document type: Article Affiliation country: United kingdom Country of publication: United States